Search
 Fulcrum Pharma - Providing Global Expert Solutions

Publications

BioPharma Development Advisor

  

What's New in Regulatory Affairs?

The BioPharma Development Advisor is an interactive monthly newsletter that provides information to help you get your products from the lab to the market. Each issue directly addresses the concerns of a 21st century pharmaceutical and biotech executive (e.g., meeting regulatory requirements and staying within budget, hiring and managing staff, finding the right outsourcers).

BioPharma Development Advisor is no longer published. Please view our archives

  

A periodic update on the latest draft and new legislation from the leading regulatory authorities and trade associations.

View Current Issue

Stay informed! Enter your email address below to subscribe to What's New in Regulatory Affairs.

For Email Marketing you can trust
     

Bio Pharma Development Advisor Archives

  

What's New in Regulatory Affairs Archives
November 2008 Building Your Career through the Development of Others!The key elements of a Professional Performance Management Program
September 2008 Reflections on Metabolites in Safety Testing: The MIST Document and FDA Guidance on Safety Testing of Drug Metabolites
August 2008 Building Resilience:
Top 10 tips for coping in an ever-changing, fast-paced environment
July 2008 The Science of High-Impact Presentations
(Fewer people fear dying than fear making presentations!)
June 2008 Preparing for the Future of Pharma and Biotech: Insights from an industry leade
April 2008
 How to Run Effective Meetings: Top 10 tips for effective meeting leadership
March 2008
 Achieving Good Clinical Practice Compliance: And why it's so important
February 2008
 Criteria for Selecting a CM: A case study
January 2008
 Leading Change: Managing transitions during mergers and acquisitions
December 2007
 Understanding Metabolism in Drug Development: Metabolism data generation and its proper timing
November 2007
 The Virtualization of Drug Development: The new model for the global market
October 2007
 Pharmacovigilance in the EU: The new guidelines and how they affect clinical trials
September 2007
 A Perspective on the eCTD: How eCTD will affect pharmaceutical companies and regulatory managers
August 2007
 Drug Development in Japan: What you need to know before you go
July 2007
 Small-Molecule CMC Development vs. the Development of Biologics: Challenges, methodologies and current issues
June 2007
 The Generic Drug Scandal: What arose from its ashes?
May 2007
 Keys to Successful Preclinical Development
 

 

 



>> Back to top









Consulting Services
Development Services
Regulatory Services
Safety Services






 
Consulting Services
Development Services
Regulatory Services
Safety Services
Fulcrum Pharma











Fulcrum Pharma logo    Hemel One, Boundary Way, Hemel Hempstead, Herts HP2 7YU                       Company registration No. 3930927 | © Copyright 2009, Fulcrum Pharma plc